General guidance and information specific to applying for funding under NHLBI’s new performance-based, milestone-driven FOAs is available through the links below. If you have questions, or don’t find the information you are looking for on these pages, please contact NHLBIClinicalTrials@mail.nih.gov.
Single-site Clinical Trials (Phase II and above)
Multi-site Clinical Trials (Phase II and above)
- Frequently Asked Questions
- Proceedings of the June 29 Webinar on “Optimizing NHLBI’s Clinical Trials Enterprise: Performance Milestones and Metrics Webinar“
General Information and Policies
Proceedings of the June 29 Webinar on “Optimizing NHLBI’s Clinical Trials Enterprise: Performance Milestones and Metrics Webinar06/29/2016
The National Heart, Lung, and Blood Institute, part of the National Institutes of Health is working to facilitate the conduct and management of clinical trials by establishing clear milestones and metrics of progress through the Institute’s Funding Opportunity Announcements (FOAs) – the notices by which NHLBI solicits applications for research from its investigator community. This video provides an overview of those efforts and describes in depth NHLBI’s new process and expectations for applications responding to NHLBI FOAs for multi-site clinical trials in Phase II and beyond.